Symbolbild · KI-generiert
HYTN Innovations Inc
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
HYTN Innovations Inc. formulates, manufactures, markets, and sells premium products that contain psychoactive and psychotropic compounds. The company’s mission is to become the top provider of these products in all federally regulated markets. To achieve this, the company focuses on identifying market opportunities in order to quickly bring its innovative products to market through its advanced development platform.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| HYTN Innovations Inc | HYTN | CSE | 9 Mio. USD |
| AI-ML Innovations Inc. | AIML | CSE | 9 Mio. USD |
| Hemostemix Inc. | HEM | TSXV | 9 Mio. USD |
| Rhelion Life Sciences Corp. | RELH | CSE | 9 Mio. USD |
| Seegnal Inc. | SEGN | TSXV | 9 Mio. USD |
| Captiva Verde Wellness Corp. | PWR | CSE | 8 Mio. USD |
| Revive Therapeutics Ltd. | RVV | CSE | 7 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.